GLP-1 drugs like Ozempic are reshaping consumer appetites, with nearly half of users eating less beef. As this trend accelerates, meat producers face a challenge, while plant-based brands are presented with an opportunity.
The growing demand for diabetes-friendly snacks presents a lucrative opportunity for the food industry to merge taste with nutritional balance. With consumers increasingly seeking blood sugar-friendly options, a new movement related to snacking has taken root.
The 2025 Winter Fancy Food Show highlighted the rapid evolution of specialty food. From protein-packed innovations and gut-friendly fermented snacks to cacao alternatives, the show underscored how brands are redefining indulgence and health.
The future of alt-meat could very well be driven not by vegetarians but by adventurous flexitarians – omnivores eager to explore alternatives. Minimally processed plant-based options will be key, said Indy Kauer, leader of the Plant Futures Collective.
Private label continues to maintain dominance over the CPG sector: in 2024, it grew $9 billion from the year before. As a result, opportunities and innovation abound.
The quest to lower one’s biological age, which reflects physiological health rather than years lived, could soon reshape the health and wellness landscape, driven by advancements in aging research. The F&B industry has a unique opportunity to innovate products that support longevity.
The rapid adoption of weight-loss drugs is reshaping purchasing habits. Circana experts highlight opportunities for brands to align with GLP-1 users’ goals by offering tailored, portion-controlled products and leveraging personalized marketing strategies to capture this evolving market.
